Zealand Pharma to participate in upcoming investor conferences in September 2025

Core Viewpoint - Zealand Pharma A/S will participate in several investor conferences in September 2025, showcasing its focus on innovative peptide-based medicines and providing opportunities for investor engagement [1]. Conference Participation - Zealand Pharma will attend the Jefferies Swiss Healthcare Summit on September 3, where Adam Lange will host investor meetings [2]. - The company will also be present at the Cantor Global Healthcare Conference from September 3-5, with CEO Adam Steensberg hosting meetings and participating in a fireside chat on September 4 at 8:00am EDT [3]. - At the Wells Fargo Healthcare Conference from September 3-5, Adam Steensberg will host meetings and participate in a fireside chat on September 5 at 8:45am EDT [5]. - The Morgan Stanley Annual Healthcare Conference will take place from September 8-10, with Adam Lange hosting meetings on September 10 [6]. - Zealand Pharma will participate in the Bank of America Global Healthcare Conference from September 23-25, where David Kendall will host meetings and give a presentation on September 25 at 10:45am UKT [7]. - The KBC Securities Life Sciences Conference will be held on September 25, with Adam Lange hosting meetings [8]. Company Overview - Zealand Pharma A/S is a biotechnology company focused on discovering and developing peptide-based medicines, with over 10 drug candidates in clinical development, including two that have reached the market and three in late-stage development [9]. - The company has established development and commercial partnerships with various pharmaceutical companies for its marketed products [9]. - Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma also has a presence in the U.S. [10].